findmyKOL
Clinical trialNCT02091245Active, not recruitingPhase 1Interventional

Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML

SponsorDana-Farber Cancer InstituteEnrollment16Chronic Myelogenous Leukemia (CML) in Blast CrisisRefractory Acute Lymphoblastic Leukemia (ALL)Refractory Acute Myelogenous Leukemia (AML)Refractory Biphenotypic LeukemiaRefractory Mixed Lineage LeukemiaRelapsed Acute Lymphoblastic Leukemia (ALL)+3 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ucsf

    San Francisco, California, United States

  • Children'S Hospital Colorado

    Aurora, Colorado, United States

  • Children'S Healthcare of Atlanta

    Atlanta, Georgia, United States

  • Boston Children'S Hospital

    Boston, Massachusetts, United States

  • Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

  • Columbia University Medical Center

    New York, New York, United States

  • Children'S Hospital of Philadelphia

    Philadelphia, Pennsylvania, United States

  • Texas Children'S Hospital

    Houston, Texas, United States

  • Seattle Children'S Hospital

    Seattle, Washington, United States

  • Children'S Hospital of Wisconsin

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2014
Primary completion
28 Feb 2018
Completion
31 Dec 2026
Last update posted
29 May 2026
Registered enrollment
16
Registry id
NCT02091245
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.